Speaker illustration

Professor Lars Kober

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

Member of:

European Society of Cardiology

Professor of Cardiology and Consultant, MD, D.Sci Graduated from University of Copenhagen and specialist in internal medicine and cardiology. Research interests: heart failure, coronary heart disease, atrial fibrillation and the cardiovascular consequences of comorbidities, with a focus on clinical trials and epidemiology. Main research activity is clinical trials and cardiovascular epidemiology. Serves as a member of the executive committee or steering committee in a number of large trials in heart failure and ischemic heart disease. The publication list encompasses more than 750 peer reviewed papers, and includes the 2015-2019 Highly Cited Researchers listing by Thomson Reuters.

Session III: Management and Clinical Trials

Event: HFA Exam Preparatory Course

Topic: Heart Failure

Session type: Symposium

Thumbnail

Distinct features of trials on non-pharmacological interventions and on special populations

Event: HFA Clinical Trials in Heart Failure Course

Topic: Heart Failure

Session type: Symposium

Thumbnail

Clinical trial procedures

Event: HFA Clinical Trials in Heart Failure Course

Topic: Heart Failure

Session type: Symposium

Thumbnail

Smaller trials, trial updates, and other studies on heart failure (2)

Event: ESC Congress 2024

Topic: Chronic Heart Failure

Session type: Late-Breaking Science

Thumbnail

Metabolic markers in chronic coronary syndrome

Event: ESC Congress 2023

Topic: Epidemiology, Prognosis, Outcome

Session type: Moderated ePosters

Thumbnail

Current view of sudden cardiac death in heart failure

Event: Heart Failure 2023

Topic: Ventricular Arrhythmias and Sudden Cardiac Death (SCD)

Session type: Symposium

Thumbnail

Chronic heart failure - Epidemiology, prognosis, outcome 1

Event: ESC Congress 2022

Topic: Epidemiology, Prognosis, Outcome

Session type: Moderated ePosters

Thumbnail

Controversies in primary prevention of sudden cardiac death in 2021: should Class I recommended for ICD be reconsidered?

Event: Heart Failure 2021

Topic: Risk Factors and Prevention

Session type: Debate Session

Thumbnail

Who should receive the wearable cardioverter defibrillator? Evidence and risk stratification for prevention of sudden cardiac death

Event: Heart Failure 2019

Topic: Treatment

Session type: Satellite Symposium

Thumbnail

HFA FOCUS I – Difficult decision making in heart failure

Event: Heart Failure 2018

Topic: Chronic Heart Failure

Session type: HFA Focus

Thumbnail